Kelley C O’donnell
Biographic Data
| ID | 1996529 |
|---|---|
| NAME | Kelley C O’donnell |
| GIVEN NAMES | Kelley C |
| FAMILY NAME | O’donnell |
| SIGNATURE | O’DONNELL K C |
| AFFILIATIONS | Bellevue Hospital Center |
| ORCID | 0000-0001-9983-2699 |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2019 |
| LATEST PUBLICATION YEAR | 2019 |
| H-INDEX | 0 |
Psilocybin for depression: Considerations for clinical trial design
Background and aims Given the enormous global burden of depressive illness, there is an urgent need to develop novel and more effective treatments for major depressive disorder (MDD). Recent findings have suggested that psychedelic drugs may have a role in the treatment of depressive symptoms, and a number of groups are in the process of developing protocols to study this question systematically. Given the subjective quality of both the psychedel…
No prominent works on this page.
Psilocybin for depression: Considerations for clinical trial design
Background and aims Given the enormous global burden of depressive illness, there is an urgent need to develop novel and more effective treatments for major depressive disorder (MDD). Recent findings have suggested that psychedelic drugs may have a role in the treatment of depressive symptoms, and a number of groups are in the process of developing protocols to study this question systematically. Given the subjective quality of both the psychedel…
Alternative medicine (1 works) · Antidepressant (1 works) · Anxiety (1 works) · Blinding (1 works) · Chemical synthesis and alkaloids (1 works) · Clinical Psychology (1 works) · Clinical study design (1 works) · Clinical trial (1 works) · Cognition (1 works) · Hallucinogen (1 works)